- Formula re: Contains
- GR-1/RC-14 and Vaginal Flora (also called microbiota)
- General Statements: All Other Content
- In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
GR-1/RC-14 75%
Control Group 34%
Martinez, et al. Can J Microbiol 2009;55:133-138
25+ years of GR-1/RC-14 Research/Clinical studies
1988 First research on GR-1/RC-14 strains begin
27 Clinical studies published between 2001 and 2014
Fem-Dophilus introduced (2006)
- Suggested/Recommended/Usage/Directions
- Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
- Precautions re: Pregnant or Nursing or Prescription Medications
- If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.
- Formula re: Contains
- Fem-Dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosis, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote vaginal and urinary tract health.
- Formulation re: Other
- A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.
- Storage
- Fem-Dophilus does not require refrigeration and can be stored at room temperature. Refrigeration will, however, extend the shelf life. Avoid temperatures above 77 degrees F (25 degrees C).
- Precautions re: Children